Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCOTRIM, Helma P.
dc.contributor.authorOLIVEIRA, Claudia P.
dc.contributor.authorCOELHO, Henrique Sergio M.
dc.contributor.authorALVARES-DA-SILVA, Mario R.
dc.contributor.authorNABUCO, Leticia
dc.contributor.authorPARISE, Edison Roberto
dc.contributor.authorIVANTES, Claudia
dc.contributor.authorMARTINELLI, Ana L. C.
dc.contributor.authorGALIZZI-FILHO, Joao
dc.contributor.authorCARRILHO, Flair J.
dc.contributor.groupauthorSBH Brazilian HCC-NASH Survey
dc.date.accessioned2016-12-20T16:37:47Z
dc.date.available2016-12-20T16:37:47Z
dc.date.issued2016
dc.description.abstractOBJECTIVE: The majority of cases of hepatocellular carcinoma have been reported in individuals with cirrhosis due to chronic viral hepatitis and alcoholism, but recently, the prevalence has become increasingly related to nonalcoholic steatohepatitis around the world. The study aimed to evaluate the clinical and histophatological characteristics of hepatocellular carcinoma in Brazilians' patients with nonalcoholic steatohepatitis at the present time. METHODS: Members of the Brazilian Society of Hepatology were invited to complete a survey regarding patients with hepatocellular carcinoma related to nonalcoholic steatohepatitis. Patients with a history of alcohol intake (420 g/day) and other liver diseases were excluded. Hepatocellular carcinoma diagnosis was performed by liver biopsy or imaging methods according to the American Association for the Study of Liver Diseases' 2011 guidelines. RESULTS: The survey included 110 patients with a diagnosis of hepatocellular carcinoma and nonalcoholic fatty liver disease from nine hepatology units in six Brazilian states (Bahia, Minas Gerais, Rio de Janeiro, Sao Paulo, Parana and Rio Grande do Sul). The mean age was 67 +/- 11 years old, and 65.5% were male. Obesity was observed in 52.7% of the cases; diabetes, in 73.6%; dyslipidemia, in 41.0%; arterial hypertension, in 60%; and metabolic syndrome, in 57.2%. Steatohepatitis without fibrosis was observed in 3.8% of cases; steatohepatitis with fibrosis (grades 1-3), in 27%; and cirrhosis, in 61.5%. Histological diagnosis of hepatocellular carcinoma was performed in 47.2% of the patients, with hepatocellular carcinoma without cirrhosis accounting for 7.7%. In total, 58 patients with cirrhosis had their diagnosis by ultrasound confirmed by computed tomography or magnetic resonance imaging. Of these, 55% had 1 nodule; 17%, 2 nodules; and 28%, >= 3 nodules. CONCLUSIONS: Nonalcoholic steatohepatitis is a relevant risk factor associated with hepatocellular carcinoma in patients with and without cirrhosis in Brazil. In this survey, hepatocellular carcinoma was observed in elevated numbers of patients with steatohepatitis without cirrhosis.
dc.description.indexMEDLINE
dc.description.sponsorshipSociedade Brasileira de Hepatologia/SBH (Brazilian Society of Hepatology)
dc.identifier.citationCLINICS, v.71, n.5, p.281-284, 2016
dc.identifier.doi10.6061/clinics/2016(05)07
dc.identifier.eissn1980-5322
dc.identifier.issn1807-5932
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/17074
dc.language.isoeng
dc.publisherHOSPITAL CLINICAS, UNIV SAO PAULO
dc.relation.ispartofClinics
dc.rightsopenAccess
dc.rights.holderCopyright HOSPITAL CLINICAS, UNIV SAO PAULO
dc.subjectNon-alcoholic Fatty Liver Disease
dc.subjectNonalcoholic Steatohepatitis
dc.subjectHepatocellular Carcinoma
dc.subjectFatty Liver
dc.subject.othernatural-history
dc.subject.othermanagement
dc.subject.otherdna
dc.subject.wosMedicine, General & Internal
dc.titleNonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalCOTRIM, Helma P.:Univ Fed Bahia, Dept Med, Serv Gastrohepatol, Salvador, BA, Brazil
hcfmusp.author.externalCOELHO, Henrique Sergio M.:Univ Fed Rio de Janeiro, Dept Clin Med, Rio De Janeiro, RJ, Brazil
hcfmusp.author.externalALVARES-DA-SILVA, Mario R.:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dept Med Interna, Serv Gastroenterol, Porto Alegre, RS, Brazil
hcfmusp.author.externalNABUCO, Leticia:Hosp Fed Servidores Estado, Serv Clin Med, Setor Hepatol, Rio De Janeiro, RJ, Brazil
hcfmusp.author.externalIVANTES, Claudia:Hosp Nossa Senhora Gracas, Serv Gastroenterol Hepatol Transplante Hepat, Curitiba, PR, Brazil
hcfmusp.author.externalMARTINELLI, Ana L. C.:Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Gastroenterol, Ribeirao Preto, SP, Brazil
hcfmusp.author.externalGALIZZI-FILHO, Joao:Univ Fed Minas Gerais, Dept Clin Med, Belo Horizonte, MG, Brazil
hcfmusp.citation.scopus20
hcfmusp.contributor.author-fmusphcCLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA
hcfmusp.contributor.author-fmusphcEDISON ROBERTO PARISE
hcfmusp.contributor.author-fmusphcFLAIR JOSE CARRILHO
hcfmusp.description.beginpage281
hcfmusp.description.endpage284
hcfmusp.description.issue5
hcfmusp.description.volume71
hcfmusp.origemWOS
hcfmusp.origem.pubmed27276398
hcfmusp.origem.scieloSCIELO:S1807-59322016000500281
hcfmusp.origem.scopus2-s2.0-84973345566
hcfmusp.origem.wosWOS:000379039100007
hcfmusp.publisher.citySAO PAULO
hcfmusp.publisher.countryBRAZIL
hcfmusp.relation.referenceBruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933
hcfmusp.relation.referenceBruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
hcfmusp.relation.referenceBugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168
hcfmusp.relation.referenceCauchy F, 2013, BRIT J SURG, V100, P113, DOI 10.1002/bjs.8963
hcfmusp.relation.referenceChagas AL, 2009, BRAZ J MED BIOL RES, V42, P958, DOI 10.1590/S0100-879X2009005000019
hcfmusp.relation.referenceCleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
hcfmusp.relation.referenceCotrim HP, 2000, AM J GASTROENTEROL, V95, P3018, DOI 10.1016/S0002-9270(00)02034-7
hcfmusp.relation.referenceDongiovanni P, 2014, WORLD J GASTROENTERO, V20, P12945, DOI 10.3748/wjg.v20.i36.12945
hcfmusp.relation.referenceEl-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
hcfmusp.relation.referenceFlores Avegail, 2014, Clin Med Insights Oncol, V8, P71, DOI 10.4137/CMO.S9926
hcfmusp.relation.referenceHu WW, 2002, CARCINOGENESIS, V23, P1781, DOI 10.1093/carcin/23.11.1781
hcfmusp.relation.referenceKASAI H, 1989, CANCER RES, V49, P2603
hcfmusp.relation.referenceKikuchi L, 2014, AM J CLIN ONCOL
hcfmusp.relation.referenceKim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023
hcfmusp.relation.referenceKirstein MM, 2014, DIGEST DIS, V32, P545, DOI 10.1159/000360499
hcfmusp.relation.referenceLeclercq IA, 2000, HEPATOLOGY, V32, p302A
hcfmusp.relation.referenceLlovet JM, 2012, J HEPATOL, V56, P908
hcfmusp.relation.referenceParanagua-Vezozzo DC, 2014, ANN HEPATOL, V13, P386
hcfmusp.relation.referenceParkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440
hcfmusp.relation.referenceReeves H, 2012, J HEPATOL, V56, P341
hcfmusp.relation.referenceRoskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
hcfmusp.relation.referenceWakai T, 2011, J GASTROINTEST SURG, V15, P1450, DOI 10.1007/s11605-011-1540-8
hcfmusp.relation.referenceYang ShiQi, 2001, Cancer Research, V61, P5016
hcfmusp.relation.referenceYasui K, 2012, HEPATOL RES, V42, P767, DOI 10.1111/j.1872-034X.2012.00986.x
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication6fe5bca4-b5ef-47da-b77a-5e60d87e165f
relation.isAuthorOfPublication34596832-6ff8-4b68-9dab-7ef2c95005c2
relation.isAuthorOfPublication9221b8d6-ad80-46e5-a56f-fb3b28a8c155
relation.isAuthorOfPublication.latestForDiscovery6fe5bca4-b5ef-47da-b77a-5e60d87e165f
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_COTRIM_Nonalcoholic_steatohepatitis_and_hepatocellular_carcinoma_Brazilian_survey_2016.PDF
Tamanho:
275.81 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)